STAGE III SINONASAL CANCER AJCC V8
Clinical trials for STAGE III SINONASAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III SINONASAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III SINONASAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe for people with advanced head and neck cancer. Ipatasertib may help stop cancer cells from growing. The study involves about 46 adults and aims to find the…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Immunotherapy combo may boost sinus cancer treatment before surgery
Disease control Recruiting nowThis study is for people with a type of sinus cancer called sinonasal squamous cell carcinoma. It compares standard chemotherapy alone to chemotherapy plus an immunotherapy drug (cemiplimab) given before surgery. The goal is to see if adding immunotherapy helps shrink tumors more…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC